Status:
COMPLETED
Post-Operative Treatment With Ketorolac After Abdominal Myomectomy
Lead Sponsor:
Ascher-Walsh, Charles, M.D.
Collaborating Sponsors:
New York Presbyterian Hospital
Icahn School of Medicine at Mount Sinai
Conditions:
Febrile Morbidity
Pain
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine if ketorolac, given after abdominal myomectomy, will decrease the frequency of post-oerative fevers as well as improve post-operative pain management.
Eligibility Criteria
Inclusion
- Ant patient undregoing abdominal myomectomy
Exclusion
- Patients with contraindication to NSAIDs including history of peptic ulcer disease, renal disease, bleeding diathesis, or hypersensitivity to NSAIDS
Key Trial Info
Start Date :
September 1 1999
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2001
Estimated Enrollment :
112 Patients enrolled
Trial Details
Trial ID
NCT00845754
Start Date
September 1 1999
End Date
August 1 2001
Last Update
February 18 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University Medical Center
New York, New York, United States, 10032